Efficacy and safety of envafolimab plus lenvatinib combined with TACE in initially unresectable hepatocellular carcinoma: An open-label, single-arm, phase II study

被引：0
|
作者：
Bai, Xueli
Chen, Yiwen
Zhang, Junlei
Hu, Wendi
Li, Xiang
Shen, Yan
Zhang, Min
Wu, Jian
Gao, Shunliang
Yu, Jun
Que, Risheng
Zhang, Yun
Yang, Fuchun
Xia, Weiliang
Zhang, Aibin
Tang, Xiaofeng
Liang, Tingbo
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Sch Med, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4108
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma
    Kilgour, James M.
    Shah, Aatman
    Urman, Nicole M.
    Eichstadt, Shaundra
    Do, Hanh N.
    Bailey, Irene
    Mirza, Amar
    Li, Shufeng
    Oro, Anthony E.
    Aasi, Sumaira Z.
    Sarin, Kavita Y.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4717 - 4725
  • [42] A phase II open-label study of cetuximab in unresectable hepatocellular carcinoma: Final results
    Gruenwald, V.
    Wilkens, L.
    Gebel, M.
    Greten, T. F.
    Kubicka, S.
    Ganser, A.
    Manns, M. P.
    Malek, N. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Efficacy and safety analysis of donafenib combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A prospective, single-arm, single center, phase II clinical study.
    Li, Jinpeng
    Chen, Hua
    Song, Jinlong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study
    Chen, Ruiqing
    Li, Lingbing
    Li, Ye
    Song, Ke
    Shen, Chenyu
    Ma, Pengkai
    Wang, Zhijun
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (03) : 1367 - 1375
  • [45] HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
    Lin, Shi-Ming
    Lu, Sheng-Nan
    Chen, Ping-Tsung
    Jeng, Long-Bin
    Chen, Shinn-Cherng
    Hu, Chi-Tan
    Yang, Sien-Sing
    Le Berre, Marie-Aude
    Liu, Xuan
    Mitchell, David Y.
    Prins, Klaas
    Grevel, Joachim
    Pena, Carol A. E.
    Meinhardt, Gerold
    HEPATOLOGY INTERNATIONAL, 2017, 11 (02) : 199 - 208
  • [46] Donafenib combined with camrelizumab and transarterial chemoembolization (TACE) as conversion therapy for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm, phase II study.
    Cao, Yajuan
    Zhang, Xuebin
    Yue, Yang
    Peng, Jin
    Li, Binghua
    Shi, Jiong
    Tang, Min
    Chen, Chaobo
    Su, Ke
    Zhang, Laizhu
    Cheng, Chunxiao
    Yu, Decai
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
    Shi-Ming Lin
    Sheng-Nan Lu
    Ping-Tsung Chen
    Long-Bin Jeng
    Shinn-Cherng Chen
    Chi-Tan Hu
    Sien-Sing Yang
    Marie-Aude Le Berre
    Xuan Liu
    David Y. Mitchell
    Klaas Prins
    Joachim Grevel
    Carol A. E. Peña
    Gerold Meinhardt
    Hepatology International, 2017, 11 : 199 - 208
  • [48] Efficacy and safety analysis of TACE plus PEI plus lenvatinib compared with TACE plus lenvatinib for the treatment of hepatocellular carcinoma with PVTT: a retrospective study
    Lu, Haohao
    Zheng, Chuansheng
    Liang, Bin
    Xia, Xiangwen
    Fan, Hongjie
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [49] Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
    Wirth, Lori J.
    Brose, Marcia S.
    Sherman, Eric J.
    Licitra, Lisa
    Schlumberger, Martin
    Sherman, Steven, I
    Bible, Keith C.
    Robinson, Bruce
    Rodien, Patrice
    Godbert, Yann
    De La Fouchardiere, Christelle
    Newbold, Kate
    Nutting, Christopher
    Misir, Soamnauth
    Xie, Ran
    Almonte, Ana
    Ye, Weifei
    Cabanillas, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (21) : 2359 - +
  • [50] Protocol of the RACB study: a multicenter, single-arm, prospective study to evaluate the efficacy of resection of initially unresectable hepatocellular carcinoma with atezolizumab combined with bevacizumab
    Masayuki Okuno
    Takamichi Ishii
    Akihiko Ichida
    Akihiko Soyama
    Nobuyuki Takemura
    Seiko Hirono
    Susumu Eguchi
    Kiyoshi Hasegawa
    Yasuharu Sasaki
    Kohei Uemura
    Norihiro Kokudo
    Etsuro Hatano
    BMC Cancer, 23 (1)
12345